CME: Attention Deficit Hyperactivity Disorder (ADHD) in Adults: Updates from APA 2019
Activity Description / Statement of Need:
In this online CME self-learning activity:
ADHD is a common neuropsychiatric disorder, affecting more than 2-3% of adults in the United States. ADHD is characterized by inattentive and/or hyperactive symptoms. Inattentive symptoms include inattention, distractibility and procrastination whereas hyperactive symptoms include impatience, restlessness, and impulsiveness. The presence of the disorder has a significant impact on health, education, and family situations.
The stimulant drug class presently represents first-line pharmacotherapy. There had previously been concern about the health risks of pharmacotherapy. However, time has brought additional experience with the medication, as ADHD medication use has risen by over 35% overall recently and over 53% in adults. Aside from experience, while simulants increase surrogate markers of heart rate and blood pressure by approximately 10 increments, there does not appear to be an increased risk of a serious adverse cardiovascular events. Another concern in recent years that may have been addressed is prescription drug abuse in children and young adults; research is now finding a significant gap between perceptions of abuse of ADHD stimulant medications and actual rates of misuse and abuse.
This activity is intended to be a one-hour learning activity focused on ADHD and its complications, designed to bring healthcare providers up to date in their practice and give them a sense of coming changes to practice and the literature.
Target Audience:
The following healthcare professionals: psychiatrists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in psychiatry; and any other healthcare professionals with an interest in or who clinically encounter pediatric patients with ADHD.
Commercial Support Disclosure: This program is supported by an educational grant from Shire Pharmaceuticals.
Learners may participate in this activity free of charge.
Release Date: October 01, 2019 -- Expiration Date: October 01, 2021
Faculty: Michael Enenbach, MD
Agenda
|
- Faculty member introduction, disclosures, overview of ADHD in adults |
|
- Major findings from APA 2019, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice (specific content contingent upon conference content) |
|
- Predicted of applicability to clinical practice and patient cases, where relevant |
|
- Concluding remarks |
Learning Objectives
By the end of the session the participant will be able to:
- Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to disease diagnosis and apply them to patient cases.
- Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to evaluation of degree therapeutic success and apply them to patient cases.
- Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to emerging therapies and apply them to patient cases.
- Summarize the most impactful findings presented at the APA 2019 meeting relating to ADHD in adults related to quantifying benefit and risk of disease progression and apply them to patient cases.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: ScientiaCME designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physicians: For applicable courses, to attain maintenance of certification (MOC) credit, you must enter your board certification ID # and birth date correctly. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC credit for this activity. Please note: not all activities on this site provide MOC credit. If this activity does not specify that it provides MOC credit in the "Accreditation" section on this page, then it does NOT provide MOC credit.
Pharmacists
ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This activity is approved for 1.00 hours (0.10 CEUs) of continuing education. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE # 0574-0000-19-037-H01-P. CPE credit effective 10/1/19 and expires 10/1/21. This is a Knowledge (K)-type activity.
Pharmacists: You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.
Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.
Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Michael Enenbach, MD , Associate Clinical Professor, UCLA, has no relevant financial disclosures.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant financial disclosures.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowedge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Take the post-test
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Additional Courses That Are Related To This Activity
Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: Updates from APA 2019
Updates in the management of insomnia: Therapeutic updates and optimizing treatment
Bipolar and mood disorder: Therapeutic updates and best practices